Giulia Orlando
@giuliaorlandogo.bsky.social
180 followers 260 following 3 posts
Epigenetic reprogramming, single-cell, gene regulation, cancer biologist. Group Leader at ‪@oncology.ox.ac.uk‬. Mom of 2. https://www.oncology.ox.ac.uk/research/research-groups/orlando-group
Posts Media Videos Starter Packs
Pinned
giuliaorlandogo.bsky.social
Excited to announce that this week I have officially started my lab at @oncology.ox.ac.uk. Grateful for all the support I received by colleagues and mentors Adam Mead, Irene Roberts, @bethpsaila.bsky.social, @houlstonlab-icr.bsky.social and many others without whom this would have not been possible.
Reposted by Giulia Orlando
sibucz.bsky.social
New CRUK Post-doc position in our group. #mutationalorder #multiomics #cancer.
my.corehr.com/pls/uoxrecru...
Job Details
my.corehr.com
giuliaorlandogo.bsky.social
Excited to announce that this week I have officially started my lab at @oncology.ox.ac.uk. Grateful for all the support I received by colleagues and mentors Adam Mead, Irene Roberts, @bethpsaila.bsky.social, @houlstonlab-icr.bsky.social and many others without whom this would have not been possible.
Reposted by Giulia Orlando
trevorgraham.bsky.social
Studying cancer evolution needs multi-region or single cell seq for phylogenetics, right? Amazingly (I think!) we found single-sample bulk methylation suffices, via analysis of "fluctuating methylation". In @nature.com today led by brilliant @calumgabbutt.bsky.social www.nature.com/articles/s41...
Fluctuating DNA methylation tracks cancer evolution at clinical scale - Nature
Cancer evolutionary dynamics are quantitatively inferred using a method, EVOFLUx, applied to fluctuating DNA methylation.
www.nature.com
Reposted by Giulia Orlando
leukaemiauk.bsky.social
A fantastic keynote lecture from @bethpsaila.bsky.social, Professor of Haematology @imm.ox.ac.uk @ox.ac.uk, for our final talk of the day. 💬
Professor Beth Psaila delivers a talk to attendees at the Annual Science Seminar. A presentation screen reads, ‘Quelling the flames - the inflammatory niche in myelofibrosis’.
Reposted by Giulia Orlando
weitinglu.bsky.social
I am delighted to announce that I am starting my lab next month in @oncology.ox.ac.uk @ox.ac.uk It is such a privilege to be a part of this storied institution!
Also, we are hiring - if chromosomal instability and cancer biology excite you, come join the fun!
Job Specification: lnkd.in/e8-3hyfr
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
Reposted by Giulia Orlando
l-cmurphy.bsky.social
🚨 New paper alert! 🚨 I’m thrilled and proud to share that our latest work has just been published in @science.org! 🎉 🧽

📖 Read our paper here: doi.org/10.1126/sci...

🎬 Watch a summary: youtu.be/MttCA3GGWEM

🧵 Or keep reading for the key points! 🔑 1/19
Reposted by Giulia Orlando
elizsmckenna.bsky.social
Now online in Cancer Discovery @aacrjournals.bsky.social: Systematic Evaluation of GAPs & GEFs Identifies a Targetable Dependency for Hematopoietic Malignancies - by Pu Zhang, Zhendong Cao, Anthony Daniyan, Omar Abdel-Wahab, Junwei Shi, et al. doi.org/10.1158/2159...
Reposted by Giulia Orlando
m-olcina.bsky.social
Thrilled to share our latest work - we describe a novel and therapeutically relevant mechanism underlying dysregulation of innate immune receptor C5aR1 in the tumour microenvironment. Thanks and congratulations to all authors!

www.nature.com/articles/s41...
Reposted by Giulia Orlando
jieyang437.bsky.social
We're recruiting a postdoc to join my lab at @oncology.ox.ac.uk & @oxcio.bsky.social to understand immune regulation in cancer and develop new approaches for cancer prevention and metastasis.

Deadline: 11 August 2025
my.corehr.com/pls/uoxrecru...

Lab info: www.oncology.ox.ac.uk/team/jie-yang
Job Details
my.corehr.com
giuliaorlandogo.bsky.social
Exciting news!!! We are recruiting a RA to join my lab at
‪@oncology.ox.ac.uk‬ to study epigenetic reprogramming in stem cells and within the TME using colon organoids

www.oncology.ox.ac.uk/team/giulia-...

Deadline 2nd of July (my.corehr.com/pls/uoxrecru...)

Re-post are very welcome!
my.corehr.com
Reposted by Giulia Orlando
ckbrierley.bsky.social
🚨🚨Paper out! 🚨🚨

Delighted to share our work, now published in ‪@natgenet.nature.com‬ 🧬!
shorturl.at/94s5S

We identified a targetable, chromothripsis-associated genetic event in blast phase (BP) MPN, a particularly poor prognostic subtype of acute leukaemia. 1/n

Illustration: Hratch Arbach
🧵👇
Reposted by Giulia Orlando
abattacks.bsky.social
Different flavour of post from me today!

A bunch of us in the lab at the @imm.ox.ac.uk are taking up Bone Cancer Research Trust (BCRT)'s June rowing challenge to both raise funds and awareness:

www.justgiving.com/fundraising/...

Please share/donate if you can!
HSCB lab rows 100km each for bone cancer research
Help Abdullah Khan raise money to support Bone Cancer Research Trust
www.justgiving.com
Reposted by Giulia Orlando
Reposted by Giulia Orlando
larsplus.bsky.social
Out @nature.com: Clonal tracing with somatic epimutations

🧬 Single cell methylome encodes cell state & clonal identity

🔨 EPI-Clone reads out both (+mutations, +RNA) at scale

🩸 Clonal expansions of HSCs are universal from age 50, not driven by CH mutations

doi.org/10.1038/s415...
🧵
Clonal tracing with somatic epimutations reveals dynamics of blood ageing - Nature
The discovery that DNA methylation of different CpG sites can serve as digital barcodes of clonal identity led to the development of EPI-Clone, an algorithm that enables single-cell lineage tracing th...
doi.org
Reposted by Giulia Orlando
brooks-lab.bsky.social
📣We’re hiring a Postdoc!
Join my new lab at the University of Oxford to investigate therapy resistance in brain cancer.

⏰Deadline: 16 June 2025

Apply 👇
my.corehr.com/pls/uoxrecru...

Boosts appreciated!

#PostdocJobs #CancerResearch #BrainCancer
https://my.corehr.com/pls/uoxrecruit…
Reposted by Giulia Orlando
leukaemiauk.bsky.social
Huge thanks to our John Goldman Fellow, Dr Giulia Orlando, for giving some of our supporters a special tour of her lab @ox.ac.uk and sharing more about her research into juvenile myelomonocytic leukaemia (JMML). An incredibly inspiring day! 🔬
Five people are standing next to a sign in front of a large building at the University of Oxford. The sign reads, ‘MRC Weatherall Institute of Molecular Medicine’. Three women are standing next to a sign in front of a large building at the University of Oxford. The sign reads, ‘MRC Weatherall Institute of Molecular Medicine’. An image of a MacBook laptop open on a desk. On the screen is a presentation with the title, ‘In search of a new targeted therapy for childhood leukaemia’. The presentation is being shown in a live video call.
Reposted by Giulia Orlando
larsplus.bsky.social
Out in Cell @cp-cell.bsky.social: Design principles of cell-state-specific enhancers in hematopoiesis
🧬🩸 screen of fully synthetic enhancers in blood progenitors
🤖 AI that creates new cell state specific enhancers
🔍 negative synergies between TFs lead to specificity!
www.cell.com/cell/fulltex...
🧵
Design principles of cell-state-specific enhancers in hematopoiesis
Screen of minimalistic enhancers in blood progenitor cells demonstrates widespread dual activator-repressor function of transcription factors (TFs) and enables the model-guided design of cell-state-sp...
www.cell.com
Reposted by Giulia Orlando
michaelranes.bsky.social
Job Alert 🔊🔊
Looking for your first or next Postdoc position? Then don't look further, apply to this opportunity to join our lab to tackle the next big challenges in the Wnt signalling field. Experience in protein biochemistry and in vitro cell biology is essential for this post tinyurl.com/2p9rndfy
Reposted by Giulia Orlando
Reposted by Giulia Orlando
bethpsaila.bsky.social
Exciting job opportunities here for *TWO* computational researchers to contribute to a new collaborative effort between the @imm.ox.ac.uk and @ludwigcancer.bsky.social focussing on progression to high risk blood cancers and secondary leukaemia. Come join our brilliant team!
marketatomkova.bsky.social
We are recruiting! Senior postdoc in computational cancer genomics/epigenomics @ludwigcancer.bsky.social @ox.ac.uk. Lead research into epigenetic drivers of secondary AML with rich omics data + strong clinical/wet-lab collaborations.
cutt.cx/YUoB
We look forward hearing from you!

#epigenetics #jobs